Millennium Management’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
BCIM
CI
JSAM
Millennium Management's PPH Position: Q4 2025 in Review
Millennium Management sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2025, closing a stake of 32,900 shares — an estimated $2.97M sold.
Millennium Management first reported a position in PPH in Q4 2014 and held it in 14 quarters. The position peaked at $2.97M in Q3 2025. 146 funds tracked by Wall St. Rank hold PPH as of Q4 2025.
- Millennium Management reported no remaining VanEck Pharmaceutical ETF position as of Q4 2025 after selling out during the quarter.
- Millennium Management sold 32,900 VanEck Pharmaceutical ETF shares in Q4 2025, an estimated $2.97M.
- Millennium Management first reported a position in VanEck Pharmaceutical ETF in Q4 2014 and held it in 14 quarters.
- Millennium Management's VanEck Pharmaceutical ETF position peaked at $2.97M in Q3 2025.
- 146 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2025.
Based on Millennium Management's 13F filing for Q4 2025, filed 17 Feb 2026.